Memantine Treatment for Improving Rehabilitation Outcomes and Preventing Depression in Older Adults
Depression
About this trial
This is an interventional treatment trial for Depression focused on measuring Major depressive disorder, Rehabilitating, Elderly, Apathy
Eligibility Criteria
Inclusion Criteria: Admission to a skilled nursing facility for rehabilitation within 3 months of recent disabling medical event (e.g., hip fracture) Medically stable (e.g., no active seizures, delirium, unstable pulse/blood pressure) Exclusion Criteria: Aphasia or cognitive impairments sufficiently severe to prevent valid assessment (e.g., a score of less than 22 on the Mini Mental State Examination) Current major depressive episode History of or current psychosis or mania Current substance or alcohol abuse or dependence (within 3 months of study entry) Current use of memantine Sensitivity or contraindication to memantine End-stage kidney, liver, heart, or lung disease Recent hemorrhagic stroke A FIM score of greater than 70 (on a 91 point scale)
Sites / Locations
- University of Pittsburgh Medical Center
Arms of the Study
Arm 1
Arm 2
Experimental
Placebo Comparator
Memantine (1)
Placebo (2)
Memantine for 12 weeks
Placebo for 12 weeks